Literature DB >> 8513022

In vitro cultivation of the third and fourth stage larvae of Angiostrongylus cantonensis.

H Hata1.   

Abstract

The third and fourth stage larvae of Angiostrongylus cantonensis were cultured in various media. When the third stage larvae were cultured in RPMI 1640 supplemented with 20% fetal calf serum for four weeks, about 30% developed to the late third stage. On the other hand, when the fourth stage larvae recovered from rat brains were cultured in Waymouth's chemically defined medium (MB 752/1) for one week, the worms grew rapidly and 74% developed into young adults. The mean body length of the worms in Waymouth's medium showed a 1.4-fold increase in size compared with that before culture.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513022     DOI: 10.1292/jvms.55.345

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  4 in total

1.  Cloning and characterization of a novel cathepsin B-like cysteine proteinase from Angiostrongylus cantonensis.

Authors:  Mei Cheng; Xiao Yang; Zhuoya Li; Hualiang He; Zhenyu Qu; Ai He; Zhongdao Wu; Ximei Zhan
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

2.  Angiostrongylus cantonensis: An optimized cultivation of this parasitic nematode under laboratory conditions.

Authors:  Hui Xie; Dongjuan Yuan; Shiqi Luo; Xingda Zeng; Xin Zeng; Ping He; Zhiyue Lv; Zhongdao Wu
Journal:  Parasitol Res       Date:  2017-06-14       Impact factor: 2.289

3.  Preliminary molecular characterization of the human pathogen Angiostrongylus cantonensis.

Authors:  Hualiang He; Mei Cheng; Xiao Yang; Jinxiu Meng; Ai He; Xiaoying Zheng; Zhuoya Li; Pengjuan Guo; Zhihua Pan; Ximei Zhan
Journal:  BMC Mol Biol       Date:  2009-10-25       Impact factor: 2.946

4.  Angiostrongylus cantonensis (Nematode: Metastrongiloidea): in vitro cultivation of infective third-stage larvae to fourth-stage larvae.

Authors:  Rong-Jyh Lin; Jie-Wen He; Li-Yu Chung; June-Der Lee; Jiun-Jye Wang; Chuan-Min Yen
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.